Skip to main content
ANAPTYSBIO, INC logo

ANAPTYSBIO, INC — Investor Relations & Filings

Ticker · ANAB ISIN · US0327241065 LEI · 529900HH4WQT03IG1A12 US Professional, scientific and technical activities
Open in API
Filings indexed 636 across all filing types
Latest filing 2021-05-04 Earnings Release
Country US United States of America
Listing US ANAB

About ANAPTYSBIO, INC

https://www.anaptysbio.com/

AnaptysBio, Inc. is a clinical-stage biotechnology company that focuses on the discovery and development of innovative immunology therapeutics. The company specializes in advancing immune cell-modulating antibodies designed to treat autoimmune and inflammatory diseases. Its therapeutic candidates target key pathways in the immune system to address significant unmet medical needs for various patient populations.

Recent filings

Filing Released Lang Actions
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 4, 2021, reporting the financial results for the quarter ended March 31, 2021. It includes a press release as an exhibit announcing quarterly financial results. The document is relatively short (4055 characters) and primarily serves as a current report to announce earnings results rather than providing a full detailed financial report. The presence of a press release announcing quarterly results aligns with the definition of an Earnings Release (ER).
2021-05-04 English
FORM 4
Director's Dealing
2021-04-28 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A filing, which is a proxy statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. It is labeled as a 'Definitive Additional Materials' proxy statement for AnaptysBio, Inc. Proxy statements are materials sent to shareholders to provide information and request votes for meetings. The document length is 2100 characters, which is relatively short and consistent with proxy solicitation materials. Therefore, this document fits the category of Proxy Solicitation & Information Statement (PSI).
2021-04-26 English
DEF 14A
Proxy Solicitation & Information Statement
2021-04-26 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-04-12 English
FORM 3
Director's Dealing
2021-04-12 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.